hUC-MSC -- Mechanisms of action

Innovation and advantages


  • (1)Animal pharmacodynamics

  • (2)Clinical trial:Good curative effect


  • (1)Safety assessment

  • (2)Clinical trial:No serious toxic and side effects were found in clinical studies

  • (3)Umbilical cord mesenchymal stem cells (MSCs) have low immunogenicity and no rejection reaction was found in all published clinical studies.

[Quality controlled]

  • (1)Method with good operability

  • (2)Process stability:The process and quality control have been standardized, and the activity of each batch of stem cell is stable。

  • (3)Industrialization

  • (4)Stability

GvHD function